ATE265437T1 - Pyrazoline, ihre herstellung und verwendung als medikamente - Google Patents

Pyrazoline, ihre herstellung und verwendung als medikamente

Info

Publication number
ATE265437T1
ATE265437T1 AT99922192T AT99922192T ATE265437T1 AT E265437 T1 ATE265437 T1 AT E265437T1 AT 99922192 T AT99922192 T AT 99922192T AT 99922192 T AT99922192 T AT 99922192T AT E265437 T1 ATE265437 T1 AT E265437T1
Authority
AT
Austria
Prior art keywords
pyrazolines
medications
production
Prior art date
Application number
AT99922192T
Other languages
English (en)
Inventor
Maria Rosa Cuberes-Altisent
Juana Maria Berrocal-Romero
Maria Montser Contijoch-Llobet
Jordi Frigola-Constansa
Original Assignee
Esteve Labor Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Labor Dr filed Critical Esteve Labor Dr
Application granted granted Critical
Publication of ATE265437T1 publication Critical patent/ATE265437T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/06—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT99922192T 1998-05-29 1999-05-27 Pyrazoline, ihre herstellung und verwendung als medikamente ATE265437T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES009801129A ES2137138B1 (es) 1998-05-29 1998-05-29 Derivados de pirazolinas, su preparacion y su aplicacion como medicamentos.
PCT/ES1999/000156 WO1999062884A1 (es) 1998-05-29 1999-05-27 Derivados de pirazolinas, su preparacion y su aplicacion como medicamentos

Publications (1)

Publication Number Publication Date
ATE265437T1 true ATE265437T1 (de) 2004-05-15

Family

ID=8303969

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99922192T ATE265437T1 (de) 1998-05-29 1999-05-27 Pyrazoline, ihre herstellung und verwendung als medikamente

Country Status (32)

Country Link
US (2) US6353117B1 (de)
EP (1) EP1083171B1 (de)
JP (1) JP4633928B2 (de)
KR (1) KR100603666B1 (de)
CN (1) CN1189459C (de)
AR (1) AR018402A1 (de)
AT (1) ATE265437T1 (de)
AU (1) AU752001B2 (de)
BG (1) BG64950B1 (de)
BR (1) BR9910801A (de)
CA (1) CA2333475C (de)
CO (1) CO5031241A1 (de)
CU (1) CU22995A3 (de)
CZ (1) CZ298391B6 (de)
DE (1) DE69916828T2 (de)
DK (1) DK1083171T3 (de)
ES (2) ES2137138B1 (de)
GE (1) GEP20043237B (de)
HU (1) HUP0102102A3 (de)
IS (1) IS2040B (de)
LT (1) LT4879B (de)
LV (1) LV12632B (de)
NO (1) NO316600B1 (de)
NZ (1) NZ508990A (de)
PL (1) PL344412A1 (de)
PT (1) PT1083171E (de)
RU (1) RU2233272C2 (de)
SI (1) SI20580B (de)
SK (1) SK285550B6 (de)
TW (1) TW572898B (de)
WO (1) WO1999062884A1 (de)
ZA (1) ZA200007638B (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6376519B1 (en) 1999-06-16 2002-04-23 Temple University-Of The Commonwealth Of Higher Education 1-(4-sulfamylaryl)-3-substituted-5-aryl-2-pyrazolines and inhibitors of cyclooxygenase-2
CO5261556A1 (es) 1999-12-08 2003-03-31 Pharmacia Corp Composiciones inhibidoras de ciclooxigenasa-2 que tiene rapido acceso de efecto terapeutico
ES2174757B1 (es) * 2001-04-06 2003-11-01 Esteve Labor Dr Empleo de derivados de firazolinas en la elaboracion de un medicamentopara la prevencion y/o el tratamiento de enfermedades proliferativas celulares.
US20030105144A1 (en) 2001-04-17 2003-06-05 Ping Gao Stabilized oral pharmaceutical composition
US6878729B2 (en) * 2001-05-04 2005-04-12 The Procter & Gamble Company Medicinal uses of dihydropyrazoles
ES2183720B1 (es) * 2001-06-18 2004-01-16 Esteve Labor Dr Procedimiento para la preparacion de derivados de 1,5-diaril-3-trifluorometil-delta2-pirazolinas racemicas y enantiomericamente puras.
ATE342722T1 (de) 2003-05-07 2006-11-15 Osteologix As Behandlung von knorpel/knochen-erkrankungen mit wasserlöslichen strontiumsalzen
ES2238923B1 (es) * 2004-02-16 2006-11-01 Laboratorios Del Dr. Esteve, S.A. Nuevos derivados pirazolinicos sustituidos.
US7998996B2 (en) * 2004-02-17 2011-08-16 Laboratorios Del Dr. Esteve S.A. Substituted pyrazoline compounds for reducing triglycerides in blood
ES2257929B1 (es) * 2004-07-16 2007-05-01 Laboratorios Del Dr. Esteve, S.A. Derivados de pirazolina, procedimiento para su obtencion y utilizacion de los mismos como agentes terapeuticos.
ES2278503B1 (es) * 2005-06-27 2008-06-16 Laboratorios Del Dr. Esteve, S.A. Epoxidacion de cetonas alfa, beta - insaturadas.
WO2007009699A2 (en) * 2005-07-15 2007-01-25 Laboratorios Del Dr. Esteve, S.A Use of substituted pyrazoline compounds and their derivatives for the treatment of cannabinoid system-associated diseases
EP1745781A1 (de) * 2005-07-15 2007-01-24 Laboratorios Del Dr. Esteve, S.A. Kombination von Cannabinoid Rezeptor Antagonist des Pyrazolin-Typs und Statin
EP1849784A1 (de) * 2006-04-26 2007-10-31 Laboratorios Del Dr. Esteve, S.A. Indolin-substituierte Pyrazolinderivate, ihre Herstellung und Anwendung als Arzneimittel
EP1749526A1 (de) * 2005-07-15 2007-02-07 Laboratorios Del Dr. Esteve, S.A. Verwendung substituierter Pyrazolinderivate zur Behandlung von Nahrungsmittel bedingten Störungen, wie Obesitas oder des metabolischen Syndroms in Patienten mit fortgeschrittener Diabetis
ES2316306B1 (es) * 2005-07-15 2009-11-23 Laboratorios Del Dr. Esteve, S.A. Combinacion de un compuesto de pirazolina sustituido y un farmaco utilizado en trastornos relacionados con los alimentos.
WO2007009702A2 (en) * 2005-07-15 2007-01-25 Laboratorios Del Dr. Esteve, S.A. Substituted pyrazoline compounds, having predetermined stereochemistry, for reducing triglycerides in blood
EP1760078A1 (de) * 2005-07-15 2007-03-07 Laboratorios Del Dr. Esteve, S.A. Substituierte Pyrazoline und Verfahren zu ihrer Herstellung
EP1743892A1 (de) * 2005-07-15 2007-01-17 Laboratorios del Dr. Esteve S.A. Substituierte Pyrazolin Verbindungen, deren Herstellung und Verwendung als Medikament
WO2007009692A1 (en) * 2005-07-15 2007-01-25 Laboratorios Del Dr. Esteve, S.A Use of substituted pyrazoline compounds for the treatment of food disorders, including obesity or metabolic syndrome in patients with developed diabetes
EP1743636A1 (de) * 2005-07-15 2007-01-17 Laboratorios Del Dr. Esteve, S.A. Kombination eines substituierten Pyrazolins und eines bei Essstörungen verwendeten Mittels
WO2007009710A2 (en) * 2005-07-15 2007-01-25 Laboratorios Del Dr. Esteve, S.A. Substituted pyrazoline compounds: methods for their preparation
EP1743643A1 (de) * 2005-07-15 2007-01-17 Laboratorios Del Dr. Esteve, S.A. Neue Darreichungsformen substituierter Pyrazolinverbindungen
WO2007009683A2 (en) * 2005-07-15 2007-01-25 Laboratorios Del Dr.Esteve, S.A. Pharmaceutical formulations of substituted pyrazoline compounds
EP1757587A1 (de) * 2005-07-15 2007-02-28 Laboratorios Del Dr. Esteve, S.A. Substituierte Pyrazolinderivate, ihre Herstellung und Verwendung als Arzneimittel
WO2007009704A2 (en) * 2005-07-15 2007-01-25 Laboratorios Del Dr. Esteve, S.A. Use of substituted pyrazoline compounds for the treatment of food disorders, including obesity or metabolic syndrome in patients with developed diabetes
ES2330993B1 (es) * 2005-07-15 2010-07-06 Laboratorios Del Dr. Esteve, S.A. Combinacion de antagonista del receptor de cannabinoides de tipo pirazolina y estatina.
ES2326724B1 (es) * 2005-07-15 2010-05-11 Laboratorios Del Dr. Esteve, S.A. Nuevas formulaciones de compuestos de pirazolina sustituidos.
EP1743642A1 (de) * 2005-07-15 2007-01-17 Laboratorios Del Dr. Esteve, S.A. Verwendung substituierter Pyrazolinverbindungen und ihrer Derivate zur Behandlung von Cannabinoidsystem-assoziierten Erkrankungen.
EP1743638A1 (de) * 2005-07-15 2007-01-17 Laboratorios Del Dr. Esteve, S.A. Pharmazeutische Formulierungen von substituierten Pyrazolinderivaten
WO2007009706A2 (en) * 2005-07-15 2007-01-25 Laboratorios Del Dr. Esteve, S.A. Substituted pyrazoline compounds, having predetermined stereochemistry, for reducing triglycerides in blood
AR061623A1 (es) * 2006-06-26 2008-09-10 Novartis Ag Derivados de acido fenilacetico
EP2114461A2 (de) * 2007-01-19 2009-11-11 Mallinckrodt Inc. Diagnostische und therapeutische cyclooxygenase-2-bindende liganden
EP3009137A1 (de) 2014-10-16 2016-04-20 Ecuphar N.V. Pyrazolinabgeleitete Verbindung und deren Verwendung in einem wöchentlichen Dosierungsschema gegen Entzündungen und Schmerzen aufgrund von degenerativen Gelenkerkrankungen bei Säugetieren
EP4029502A1 (de) 2021-01-15 2022-07-20 Ecuphar N.V. Pyrazolinabgeleitete verbindung (enflicoxib) zur verwendung bei der vorbeugung und/oder behandlung von schmerzen und entzündungen im zusammenhang mit chirurgie bei säugetieren
US20240165148A1 (en) 2021-03-15 2024-05-23 Saul Yedgar Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory diseases
US12208085B2 (en) * 2022-05-31 2025-01-28 Ecuphar Nv Pyrazoline-derived compound for use in the prevention and/or treatment of pain and inflammation associated to surgery in mammals

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2060660B (en) * 1979-10-18 1983-11-23 Bostik Ltd Adhesives containing pyrazoline activators
JPS5818363A (ja) * 1981-07-13 1983-02-02 アメリカン・サイアナミド・カンパニ− 複素環式置換アミノピラゾリン類およびその薬としての用途
AU598633B2 (en) * 1987-01-05 1990-06-28 E.I. Du Pont De Nemours And Company 1-sub-phenyl-3-sub-phenylamino(thio) carbonyl-pyrazolines as insecticides
PH27357A (en) * 1989-09-22 1993-06-21 Fujisawa Pharmaceutical Co Pyrazole derivatives and pharmaceutical compositions comprising the same
WO1996037476A1 (en) * 1995-05-25 1996-11-28 G.D. Searle & Co. Method of preparing 3-haloalkyl-1h-pyrazoles
GB9520584D0 (en) * 1995-10-09 1995-12-13 Fujisawa Pharmaceutical Co Pyrazole derivatives,processes for preparation thereof and pharmaceutical composition comprising the same

Also Published As

Publication number Publication date
CN1307566A (zh) 2001-08-08
AU752001B2 (en) 2002-09-05
KR100603666B1 (ko) 2006-07-24
ES2221382T3 (es) 2004-12-16
NO20006029L (no) 2001-01-26
HUP0102102A2 (hu) 2002-03-28
PT1083171E (pt) 2004-09-30
DK1083171T3 (da) 2004-08-09
SI20580A (sl) 2001-12-31
ES2137138B1 (es) 2000-09-16
CZ20004418A3 (en) 2001-06-13
JP4633928B2 (ja) 2011-02-16
BR9910801A (pt) 2001-11-27
AU3932999A (en) 1999-12-20
SK18072000A3 (sk) 2001-07-10
CU22995A3 (es) 2004-10-12
SI20580B (sl) 2007-10-31
LV12632A (lv) 2001-03-20
GEP20043237B (en) 2004-05-25
USRE38963E1 (en) 2006-01-31
ES2137138A1 (es) 1999-12-01
PL344412A1 (en) 2001-11-05
CO5031241A1 (es) 2001-04-27
LT4879B (lt) 2002-01-25
EP1083171A1 (de) 2001-03-14
BG105005A (en) 2001-08-31
AR018402A1 (es) 2001-11-14
JP2002516908A (ja) 2002-06-11
IS5736A (is) 2000-11-28
LV12632B (en) 2001-07-20
TW572898B (en) 2004-01-21
NZ508990A (en) 2002-12-20
EP1083171B1 (de) 2004-04-28
DE69916828T2 (de) 2005-04-14
NO316600B1 (no) 2004-03-01
BG64950B1 (bg) 2006-10-31
LT2000108A (en) 2001-09-25
DE69916828D1 (de) 2004-06-03
NO20006029D0 (no) 2000-11-28
SK285550B6 (sk) 2007-03-01
IS2040B (is) 2005-08-15
CN1189459C (zh) 2005-02-16
CA2333475A1 (en) 1999-12-09
CA2333475C (en) 2009-12-08
HUP0102102A3 (en) 2002-06-28
CZ298391B6 (cs) 2007-09-19
WO1999062884A1 (es) 1999-12-09
RU2233272C2 (ru) 2004-07-27
ZA200007638B (en) 2001-11-13
KR20010052437A (ko) 2001-06-25
US6353117B1 (en) 2002-03-05

Similar Documents

Publication Publication Date Title
ATE265437T1 (de) Pyrazoline, ihre herstellung und verwendung als medikamente
ATE286021T1 (de) Substituierte phenylderivate, ihre herstellung und verwendung
DE69627411D1 (de) Triazinderivate, ihre Herstellung und Verwendung
DE60008862D1 (de) Thienopyrimidin verbindungen, ihre herstellung und verwendung
DE69814431D1 (de) 3,3-diarylpropylamine , ihre verwendung und herstellung
ATE424202T1 (de) Substituierte 2-thio-3,5-dicyano-4-phenyl-6- aminopyridine und ihre verwendung
DE69819989D1 (de) Zusammensetzung, die Molekularsiebe vom Pentasil-Typ enthält, sowie ihre Herstellung und Verwendung
DE69529026D1 (de) Trehalose, ihre Herstellung und ihre Verwendung
ATE539062T1 (de) Bizyklishe verbindung, ihre herstellung und verwendung
DE69817611D1 (de) 2-aryl-8-oxodihydropurin-derivate, ihre herstellung, ihre verwendung als medikamentenkomponente und deren intermediate
DE59814449D1 (de) Pyrazol-Derivate, ihre Herstellung und ihre Verwendung in Arzneimitteln
DE10084442T1 (de) Kaolin-Pigmente, ihre Herstellung und Verwendung
DE59709806D1 (de) Cycloolefincopolymere, ihre verwendung und daraus hergestellte formkörper
ATE272634T1 (de) Benzothiophenderivate, verhahren zu ihrer herstellung und ihre verwendung
ATE319684T1 (de) Sulfonamidderivate, deren herstellung und deren verwendung als medikamente
DE59901120D1 (de) Kationische rutheniumkomplexe, ihre herstellung und ihre verwendung
DE69901177D1 (de) Platinkomplex, dessen herstellung und dessen therapeutische verwendung
DE69625857D1 (de) Siliconderivate, ihre Herstellung und Verwendung
DE59802590D1 (de) Cyclische Cedren-Acetale, ihre Herstellung und ihre Verwendung
ATE439439T1 (de) Disulfid-vernetzte glycoprotein-hormone, ihre herstellung und verwendung
ATE265454T1 (de) Phenyloxazol-1,4-diazabicyclo(3.2.2)nonanderiva e,ihre herstellung und ihre therapeutische verwendung
ATE533768T1 (de) Imidazol-derivate, ihre herstellung und ihre verwendung
DE59710272D1 (de) Neue alpha-hydroxysäurederivate, ihre herstellung und verwendung
DE59409541D1 (de) Bicyclen-derivate, ihre herstellung und verwendung
DE69511579D1 (de) Biozide alkohole, ihre herstellung und ihre verwendung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1083171

Country of ref document: EP